Intercept to Announce Fourth Quarter and Full Year 2022 Financial Results on March 2, 2023

Rhea-AI Summary

Intercept Pharmaceuticals (Nasdaq: ICPT) will announce its Q4 and full-year 2022 financial results on March 2, 2023, followed by a conference call at 8:30 a.m. ET. The company specializes in developing therapeutics for progressive non-viral liver diseases like primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH). Investors can access the call through the company's investor page, and a replay will be available afterward.

MORRISTOWN, N.J., Feb. 23, 2023 (GLOBE NEWSWIRE) -- Intercept Pharmaceuticals, Inc. (Nasdaq: ICPT), a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, will announce its fourth quarter and full-year 2022 financial results on Thursday, March 2, 2023. The announcement will be followed by a conference call and audio webcast at 8:30 a.m. ET.  

Participants can access the conference call live via webcast which will be available on the investor page of the company’s website at http://ir.interceptpharma.com. Participants who wish to ask a question may register here to receive dial-in numbers and a unique pin to join the call. While not required, it is recommended you join 10 minutes prior to the event's start. A replay of the call will be available on Intercept’s website following the completion of the call.   
   
About Intercept   
Intercept is a biopharmaceutical company focused on the development and commercialization of novel therapeutics to treat progressive non-viral liver diseases, including primary biliary cholangitis (PBC), nonalcoholic steatohepatitis (NASH) and severe alcohol-associated hepatitis (sAH). For more information, please visit www.interceptpharma.com or connect with the Company on Twitter and LinkedIn.
  
Contact   
For more information about Intercept, please contact:   

Investor inquiries: investors@interceptpharma.com 

Media inquiries: media@interceptpharma.com 
  

 

FAQ

When will Intercept Pharmaceuticals announce its 2022 financial results?

Intercept Pharmaceuticals will announce its Q4 and full-year 2022 financial results on March 2, 2023.

What time is the conference call for Intercept Pharmaceuticals?

The conference call for Intercept Pharmaceuticals will take place at 8:30 a.m. ET on March 2, 2023.

How can I listen to the conference call for Intercept Pharmaceuticals?

You can access the conference call live via webcast on Intercept Pharmaceuticals' investor page.

What diseases does Intercept Pharmaceuticals focus on?

Intercept Pharmaceuticals focuses on developing therapies for progressive non-viral liver diseases including primary biliary cholangitis (PBC) and nonalcoholic steatohepatitis (NASH).